Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver J Kennedy

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Applied Laboratory Medicine|December 31, 2020
The Enhanced Liver Fibrosis (ELF) Panel: Analyte Stability Under Common Sample Storage Conditions Used in Clinical PracticeOliver J Kennedy, Julie Parkes, Sudeep Tanwar, et al.
BMJ Open|September 29, 2020
Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney diseaseTheresa Hydes, Ryan Buchanan, Oliver J Kennedy, et al.
BMJ (Clinical Research Ed.)|November 24, 2017
Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomesRobin Poole, Oliver J Kennedy, Paul Roderick, et al.
BMC Public Health|June 22, 2021
All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank studyOliver J Kennedy, Jonathan A Fallowfield, Robin Poole, et al.
International Journal of Obesity (2005)|November 10, 2022
Child and adult adiposity and subtype-specific endometrial cancer risk: a multivariable Mendelian randomisation studyOliver J Kennedy, Cemsel Bafligil, Tracy A O'Mara, et al.
BMC Medicine|May 17, 2023
The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK BiobankTheresa J Hydes, Oliver J Kennedy, Ryan Buchanan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2024
Liver Fibrosis Assessed Via Noninvasive Tests Is Associated With Incident Heart Failure in a General Population CohortTheresa J Hydes, Oliver J Kennedy, Kate Glyn-Owen, et al.
Metabolism: Clinical and Experimental|May 25, 2025
Impact of metabolic dysfunction severity in steatotic liver disease and its interaction with liver fibrosis on all-cause mortality and multiple hepatic and extra-hepatic outcomesDaniel J Cuthbertson, Oliver J Kennedy, Josh Bilson, et al.
International Journal of STD & AIDS|August 25, 2017
2017 European guidelines for the management of genital herpesRajul Patel, Oliver J Kennedy, Emily Clarke, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 16, 2019
Coffee Consumption and Kidney Function: A Mendelian Randomization StudyOliver J Kennedy, Nicola Pirastu, Robin Poole, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Applied Laboratory Medicine|December 31, 2020
The Enhanced Liver Fibrosis (ELF) Panel: Analyte Stability Under Common Sample Storage Conditions Used in Clinical PracticeOliver J Kennedy, Julie Parkes, Sudeep Tanwar, et al.
BMJ Open|September 29, 2020
Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney diseaseTheresa Hydes, Ryan Buchanan, Oliver J Kennedy, et al.
BMJ (Clinical Research Ed.)|November 24, 2017
Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomesRobin Poole, Oliver J Kennedy, Paul Roderick, et al.
BMC Public Health|June 22, 2021
All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank studyOliver J Kennedy, Jonathan A Fallowfield, Robin Poole, et al.
International Journal of Obesity (2005)|November 10, 2022
Child and adult adiposity and subtype-specific endometrial cancer risk: a multivariable Mendelian randomisation studyOliver J Kennedy, Cemsel Bafligil, Tracy A O'Mara, et al.
BMC Medicine|May 17, 2023
The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK BiobankTheresa J Hydes, Oliver J Kennedy, Ryan Buchanan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2024
Liver Fibrosis Assessed Via Noninvasive Tests Is Associated With Incident Heart Failure in a General Population CohortTheresa J Hydes, Oliver J Kennedy, Kate Glyn-Owen, et al.
Metabolism: Clinical and Experimental|May 25, 2025
Impact of metabolic dysfunction severity in steatotic liver disease and its interaction with liver fibrosis on all-cause mortality and multiple hepatic and extra-hepatic outcomesDaniel J Cuthbertson, Oliver J Kennedy, Josh Bilson, et al.
International Journal of STD & AIDS|August 25, 2017
2017 European guidelines for the management of genital herpesRajul Patel, Oliver J Kennedy, Emily Clarke, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 16, 2019
Coffee Consumption and Kidney Function: A Mendelian Randomization StudyOliver J Kennedy, Nicola Pirastu, Robin Poole, et al.
Pageof 2